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Abstract 
Objective: This paper presents continued research toward the development of a knowledge-based 
system for the diagnosis of human toxic exposures. In particular, this research focuses on the 
challenging task of diagnosing exposures to multiple toxins. Although only 10% of toxic 
exposures in the United States involve multiple toxins, multiple exposures account for more than 
half of all toxin-related fatalities. Using simple medical mathematics, we seek to produce a 
practical decision support system capable of supplying useful information to aid in the diagnosis 
of complex cases involving multiple unknown substances. 
Methods: The system is automatically trained using data mining techniques to extract prior 
probabilities and likelihood ratios from a database managed by the Florida Poison Information 
Center (FPIC). When supplied with observed clinical effects, the system produces a ranked list 
of the most plausible toxic exposures. During testing, the system diagnosed toxins at three levels: 
identifying the substance, identifying the toxin’s major and minor categories, and identifying the 
toxin’s major category alone. To enable comparison between these three levels, accuracy was 
calculated as the percentage of exposures correctly identified in top 10% of trained diagnoses. 
Results: System evaluation utilized a dataset of 8,901 multiple exposure cases and 37,617 single 
exposure cases. Initial system testing using only multiple exposure cases yielded poor results, 
with diagnosis accuracies ranging from 18.5-50.1%. Further investigation revealed that the 
system’s inability to diagnose multiple disorders resulted from insufficient data and that the 
clinical effects observed in multiple exposures are dominated by a single substance. Including 
single exposures when training, the system achieved accuracies as high as 83.5% when 
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diagnosing the primary contributors in multiple exposure cases by substance, 86.9% when 
diagnosing by major and minor categories, and 79.9% when diagnosing by major category alone. 
Conclusions: Although the system failed to completely diagnose exposures to multiple toxins, 
the ability to identify the primary contributor in such cases may prove valuable in aiding medical 
personnel as they seek to diagnose and treat patients. As time passes and more cases are added to 
the FPIC database, we believe system accuracy will continue to improve, producing a viable 
decision support system for clinical toxicology.  
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1.  Introduction 
This paper discusses ongoing research in developing a knowledge-based system to serve as 
a decision support system for clinical toxicology. The system is automatically trained using data 
mining techniques to extract likelihood ratios and prior probabilities from a database supplied by 
the Florida Poison Information Center (FPIC). After training, the user enters the clinical effects 
(i.e., signs and symptoms) observed in a patient and the system returns a differential diagnosis of 
plausible toxic exposures in the form of a ranked list. A brief overview of the system is given in 
[1,2], while [3] offers a detailed description of system functionality when diagnosing exposures 
to a single toxin. The research presented here expands on [3] by exploring the diagnosis of 
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multiple toxic exposures. The results reveal intriguing insights into the diagnosis of multiple 
exposures in the field of toxicology. 
1.1 Motivation for diagnosing multiple disorders 
Poison control centers offer free consultations with toxicologists and other specialists in 
the field of toxicology. In many cases, consultations are a simple matter, consisting mainly of 
matching clinical effects that are known to be directly associated with the mechanisms and 
behaviors of one class of toxin. Cases that toxicologists find difficult tend to consist of multiple 
unknown toxins interacting to produce clinical effects that cannot be matched with any single 
substance. If all substances interacted linearly, determining multiple unknown drugs by their 
clinical effects would amount to identifying the drug combinations that, when summed together, 
produce the observed results. Unfortunately, many drug interactions are non-linear, interacting 
synergistically or antagonistically. Some drug combinations cause a dramatic increase in 
symptom severity, some mask symptoms normally observed with one of the drugs, and some can 
cause symptoms that normally would not appear with any of the drugs individually. Little 
documentation exists for the majority of toxic exposure combinations that can occur and, 
although many established methods for designing knowledge-based systems exist (e.g., rule-
based systems, case-based reasoning, etc.), none have fully solved the problem of diagnosing 
multiple disorders. Additionally, only a limited number of knowledge-based systems exist in the 
field of toxicology, the most prominent being a French system called SETH [4,5], a Bulgarian 
system called MEDICOTOX-CONSILIUM [6], and an Inreca (Induction and Reasoning from 
Cases) system focused on Russian intoxications [7]. None of these publications thoroughly 
discuss the diagnosis of multiple disorders, nor are the systems readily available for use by 
American toxicologists. 
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Beyond the motivation of developing technology to address an unsolved diagnostic 
problem, the more important concern is saving lives. The 2010 National Poison Data System 
(NPDS) report shows that although only 10% of reported human exposures involved multiple 
toxins, multiple toxins accounted for 58.6% of all exposure-related fatalities [8]. Being able to 
address multiple exposures is an important concern for the preservation of human lives. A 
knowledge-based system can aid in addressing multiple exposures by effectively making the 
relevant information in poison control center databases available to the toxicologist. The goal of 
the knowledge-based system presented in this paper is not to replace the toxicologist, but to act 
as a powerful consulting tool providing case-based summary data for all medical personnel that 
may encounter toxic exposure cases. Human beings have senses and intuition that are important 
for diagnosis, which computers cannot replicate. However, by offering speculative advice, the 
system may facilitate more accurate and timely diagnoses. 
1.2 Approaches to diagnosing multiple disorders 
Four primary approaches have been used when developing knowledge-based systems for 
multiple disorder diagnosis: Bayesian methods, case-based reasoning, set covering, and 
diagnostic scores. Note that, although we divide these systems into four types for the sake of 
discussion, many systems may contain aspects from multiple approaches. 
Bayesian methods revolve around Bayes’ rule of conditional probability, which requires 
statistical independence of the clinical effects used for diagnosis. As a result, much research has 
focused on the generalization of Bayes’ rule to account for dependencies within a domain (e.g., 
[9,10]). Of note, Bayesian belief networks were developed to enable dependencies to be included 
in a system’s probability calculations [11]. Examples of systems using belief networks to 
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diagnose multiple disorders include HEPAR II [12,13], MUNIN [14], and a system developed in 
the Netherlands [15]. 
Case-based reasoning enables systems to effectively create themselves from historical 
cases, unlike most complex models (including Bayesian belief networks) that generally require 
knowledge acquisition from experts [16]. Since case-based reasoning is an approach to system 
development rather than a method for reconciling uncertainty and probabilistic dependencies, 
many case-based reasoning systems also make use of other methods. Examples of systems using 
case-based reasoning to diagnose multiple exposures include ADAPtER [17] and research based 
on the SONOCONSULT knowledge base [16,18,19]. 
Set covering is a method that seeks to find combinations of disorders that can account for 
observed clinical effects. The simplicity and elegance of the approach makes it one of the most 
promising areas in research relating to multiple disorder diagnosis. Research using set covering 
to diagnose multiple exposures has been performed by Reggia et al. [20], Peng and Reggia [21-
23], Wu [24,25], and others [26,27]. 
Finally, diagnostic scores are commonly used in the medical field when diagnosing 
multiple disorders. When forming a diagnosis, the physician gathers a list of all the clinical 
effects observed in the patient. Each clinical effect has a score based on its correlation to a 
specific disorder. Calculating the sum of these scores yields a final diagnostic score, which 
corresponds to the patient’s risk of having a specific disorder. Research based on 
SONOCONSULT [28,29] provides an excellent example of a system using diagnostic scores to 
diagnose multiple disorders. This case-based system semi-automatically (i.e., the system 
generates its rules automatically but still requires an expert to oversee its development and adjust 
parameters as necessary to ensure the system functions properly) learns diagnostic rules for the 
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field of sonography. Since “understandability and interpretability of…learned models is of prime 
importance,” the system utilizes diagnostic scores because, “ideally, [a] learning method 
constructs knowledge in the same representation the human expert favors” [28]. 
2.  System approach 
Our system was developed in Microsoft Access 2002 and programmed using Visual Basic 
and SQL. The system is a hybrid, merging concepts from three of the approaches discussed 
above. Like case-based reasoning, the system relies entirely on a database of cases for diagnosis. 
Like Bayesian approaches, the core of the system is based on conditional probability calculations 
(i.e., likelihood ratios). (In fact, replacing current system calculations with the odds-ratio form of 
Bayes’ theorem [30] does not affect the order of the resultant differential diagnosis.) Like 
diagnostic scores, the system seeks to use established representations recognized in the field of 
medicine (i.e., differential diagnoses, likelihood ratios, and pre-test probabilities). 
Likelihood ratios and pre-test probabilities (prior probabilities) are commonly used 
throughout the medical field and readily understood by healthcare professionals. Furthermore, by 
assuming that each clinical effect functions as an independent diagnostic test, the calculations are 
easily combined via multiplication. For these reasons, the system utilizes tables of likelihood 
ratios and prior probabilities to produce its differential diagnosis. The basic likelihood ratio, LR+, 
is calculated as: 
















TNFP
FP
FNTP
TP
LR , (1) 
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where TP represents true positive, TN represents true negative, FP represents false positive, and 
FN represents false negative test results [30]. To prevent multiply-by-zero and divide-by-zero 
errors, a pseudocount [31] is added to the likelihood ratio: 


















TNFP
FP
FNTP
TP
Adj
LR ’ (2) 
where  is a small, positive constant. A  of 0.01 is used, unless otherwise noted. The system’s 
primary resource when generating a differential diagnosis is an exhaustive table of likelihood 
ratios, calculated using (2), relating every individual clinical effect to every possible toxic 
exposure diagnosis. In addition, the system uses a table containing the prior probability, P, of 
each toxin, which is calculated as: 
Total
Cases
P  , (3) 
where Cases is the number of cases involving a particular substance and Total is the total number 
of exposure cases in the database [32]. 
 The system’s likelihood ratios and prior probabilities were automatically trained on five 
years of case data supplied by the FPIC in Jacksonville. After cleaning the database using data 
mining techniques, 37,617 single exposure cases and 8,901 multiple exposure cases remained for 
system training. The cases in the FPIC database conform to the national standards set forth by 
the National Poison Data System (NPDS), guaranteeing that every exposure record includes the 
clinical effects and final diagnosis associated with the case. These standards not only 
accommodate the training and testing of the system, they also facilitate the portability of the 
system to other poison control centers around the United States. 
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NPDS categorizes each substance as belonging to a major and minor category. For 
example, black widow spider poison is part of the spider bites minor category, which is part of 
the bites and envenomations major category. Even if a specific substance cannot be determined, 
identifying a toxin’s general category can aid in the prompt treatment of a patient. Because of 
this, the system was trained to diagnose at three levels: substance, major and minor categories, 
and major category alone. Furthermore, the system was tested at three levels of medical 
outcomes: exposures of minor severity or worse, moderate severity or worse, and major severity 
or worse. 
System testing is performed using 10-fold cross-validation. Based on the observed clinical 
effects, combined likelihood ratios (including prior probabilities) are calculated by multiplication 
and a differential diagnosis generated in the form of a ranked list. To enable comparison between 
different diagnostic levels during testing, accuracy is calculated as the percentage of cases 
identified correctly in the top 10% of the trained diagnoses. Unless otherwise noted, trained 
diagnoses are limited to include only exposures for which a minimum of 10 recorded cases 
appeared in the database. For a more detailed discussion of system development and design 
principles, see [3]. 
3.  System testing and results 
3.1 Diagnosing multiple exposures using solely multiple exposure cases 
During the initial phase of testing, all multiple exposure cases were extracted from the 
database. NPDS standards require that each substance involved in a toxic exposure be assigned a 
sequence number that ranks the substance in accordance with its relative contribution to the 
observed clinical effects. To prevent combinatorial explosion in the initial attempts to diagnose 
multiple disorders, only the primary and secondary contributors in each multiple exposure case 
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were considered. NPDS standards also require that substances be recorded by a product specific 
code as well as a generic substance code. From this requirement, a problem arises. When 
determining the number of substances involved in an exposure, the FPIC database uses the 
product specific code. As a result, two products marketed by different companies are listed as 
separate substances, even if their active ingredient is the same. When cleaning the data, if the 
generic substance codes for the top three contributing substances were identical, the case was 
removed from the dataset. If the first two generic substance codes were identical but the third 
was different, the third substance was treated as the secondary contributor for the case. Finally, 
the multiple exposure cases were filtered so that only cases followed to a known outcome that 
produced at least minor effects in the patient were used to train and test the system. The resulting 
cleaned dataset contains 8,901 multiple exposure cases. 
When generating the multiple exposure system, each pair of primary and secondary 
contributors was trained as a single diagnosis. The original results from training and testing the 
system on multiple exposure cases are displayed in the first column of Table 1. With an accuracy 
ranging from 28.3-50.1%, the system’s deplorable performance is painfully obvious. To further 
explore this failure, the system was tested by altering the cutoff for the minimum number of 
recorded cases required to train a particular diagnosis from 10 to 15, 20, and 25. The results of 
these tests show a similar lack of accuracy (Table 1). Looking at the rows in the table from left to 
right, we can see that the performance gradually decays as the cutoff value increases. As 
discussed in [3], such an observation is expected because an increase in the minimum number of 
exposure cases lowers the number of diagnoses included in the top 10%. The most interesting 
characteristic of the data in Table 1 is that as the severity increases, the accuracy decreases. This 
observation is contrary to the results observed in the single exposure system [3]. Normally, 
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system accuracy increases with severity because more severe cases contain more clinical effects, 
making diagnosis easier for the system. 
There are a number of plausible explanations for why accuracy might decrease with 
severity, but two are particularly compelling. The first explanation is that the decrease in 
accuracy is caused by the non-linear interactions between multiple toxins. As the severity of an 
exposure increases, there is greater opportunity for a combination of toxins to produce effects not 
normally associated with any of the toxins individually. This could lower the accuracy of the 
system because the clinical effects would behave more erratically and might not correspond to 
the majority of cases. The second explanation is that the decrease in accuracy is simply caused 
by lack of quality data. As the severity cutoff becomes more stringent, fewer cases are tested 
against the system, leading to a poor sampling and quite possibly lower accuracies on average. 
Lack of quality data could account for both the low accuracy observed overall as well as the 
decrease in accuracy as the severity increases. 
Another parameter that might contribute to the system’s poor accuracy is the pseudocount 
() introduced in (2). The pseudocount is meant primarily to safeguard against multiply-by-zero 
and divide-by-zero errors, however, a small training set might cause  to adversely influence the 
diagnostic results. Table 2 compares the original system accuracy, when using a  of 0.01, to 
accuracies calculated with a  of 0.1 and 0.001. It was discovered that increasing  to 0.1 causes 
an average decrease in accuracy of 1.6%, while decreasing  to 0.001 causes an average increase 
in accuracy of only 0.1%. These results imply that a  of 0.01 yields satisfactory relative 
performance compared to other  parameters that might be selected. 
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In an attempt to improve accuracy and better understand the system’s poor performance, a 
number of system variations were tested. The resulting accuracies for these systems are 
presented in Table 3, where the column labeled “original accuracies” represents the original 
system. The first column of accuracies displays the results for a system that assumes all trained 
diagnoses are equally likely by omitting prior probabilities from its calculations. As expected, 
the system performs worse than the original. However, the results of this test do reveal a few 
important insights. Note that, unlike the original, the accuracies for diagnosis by substance as 
well as major and minor categories increase as severity increases. The significance of this 
observation is that the system is indeed processing clinical effects correctly. Thus, the accuracies 
decreasing with increased severities in the original testing are not due to the non-linear 
interactions of multiple substances. Rather, the results imply that the prior probability is 
dominating the original diagnoses. The most likely cause for this problem is lack of quality data. 
Additionally, the fact that diagnosis by major category alone still displays a decreasing accuracy 
with increasing severity fits the explanation. Major categories cover a broad variety of 
substances, making it difficult to train a general model that properly fits the major category as a 
whole. The problem is compounded when attempting to identify two different major categories 
in the same diagnosis. 
Another problem that could contribute to the low accuracy of the system is that multiple 
exposure cases can consist of more than two substances. Since the system only considers the 
primary and secondary contributors, any additional substances involved could affect the clinical 
effects in a manner not normally predicted in a case only involving two substances. To improve 
the quality of the training data, a system was created based solely on cases where exactly two 
substances are involved. The system accuracy is reported in Table 3 under the column titled 
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“double exposures.” Although this approach improves data quality, it also reduces the amount of 
training cases from 8,901 to 5,149, a data reduction of over 40%. The end results yield a nominal 
increase in the average accuracy of only 0.7%. 
Further attempts to improve accuracy resulted in two more variations of the system. The 
original system requires the correct identification of both primary and secondary contributors for 
a diagnosis to be considered successful. The first variation relaxes the constraints of the original 
system by allowing the order of the primary and secondary contributing substances to be 
reversed. Thus, diagnosing a test case with a primary contributor of A and a secondary 
contributor of B as having a primary contributor of B and a secondary contributor of A is 
considered an accurate diagnosis. As seen in Table 3 under the column labeled “order reversed,” 
the relaxed diagnosis criteria increase accuracy by an average of 8.9%. Unfortunately, the 
resulting system is still not viable, having only achieved a maximum accuracy of 56.0%. The 
second variation on the original system attempted to improve accuracy by allowing the system to 
count any diagnosis as a correct match if the primary contributor matched the primary 
contributor of the test case, regardless of the secondary contributors involved. As shown in Table 
3 under the column labeled “primary correct,” this increases the system’s accuracy drastically, 
yielding a maximum accuracy of 82.9%. It should be noted that these results are falsely 
optimistic because the most common substances involved in multiple exposures are the primary 
contributors for many different substance combinations. As a result, a number of different 
possible diagnoses could be considered “correct” diagnoses for any single test case. Additionally, 
diagnosing multiple exposures by substance has a maximum accuracy of 64.8%, which is not an 
outstanding number. In spite of these shortcomings, the final system test seems to indicate that 
the primary contributor might be the dominating force in most multiple exposure cases. For that 
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reason, the research presented in the following section focuses on diagnosing the primary 
contributor.  
3.2 Diagnosing multiple exposures with single exposure cases 
The findings in the previous section seem to indicate that the clinical effects observed in 
most multiple exposure cases are dominated by the clinical effects associated with the primary 
contributor. To test this hypothesis, a system trained entirely on single exposures was examined 
to see if it could accurately diagnose the primary contributor in multiple exposure cases. The first 
column of Table 4 shows the accuracy of the system when diagnosing the primary contributor 
for every multiple exposure case. The next column shows the results when the test cases are 
limited to double exposures. With accuracies reaching as high as 84.9%, the results confirm that 
the clinical effects observed in most multiple exposure cases are indeed dominated by those 
associated with the primary contributor. Furthermore, the evidence indicates that the poor 
performance observed in the system trained solely on multiple exposure cases was not due to 
non-linear interactions between multiple toxins. As discussed in the previous section, the 
remaining explanation for the system failure is lack of sufficient data. 
To test whether lack of data caused the poor performance observed in the system trained 
solely on multiple exposures, a system was trained using a combination of multiple exposures 
and single exposures to diagnose the primary contributor in multiple exposure cases. For training 
purposes, each multiple exposure was treated as a single exposure case with the primary 
contributor as the correct diagnosis. The system was then tested using 10-fold cross-validation on 
the multiple exposure dataset with the modification that all single exposure cases were included 
in the training set for every iteration. In a similar manner, a system trained on a combination of 
double exposures and single exposures was tested to see if it could identify the primary 
14 
 
contributor in double exposure cases. The results of these two tests are displayed in the last two 
columns of Table 4. On average, the accuracy increased by 3.3% when diagnosing multiple 
exposures and 1.8% when diagnosing only double exposures. These results indicate that valuable 
information capable of yielding greater than 80% accuracy is contained in the multiple exposure 
cases. Moreover, these results are consistent with the explanation that the system failure when 
training on multiple exposures alone was due to lack of sufficient data. It is also interesting to 
note that the system performed slightly better diagnosing multiple exposures, which generally 
should contain more extraneous clinical effects, than when diagnosing double exposures. The 
explanation is that training with multiple exposures included the information from approximately 
8,011 cases per diagnosis cycle whereas training with double exposures included approximately 
4,634 cases per diagnosis cycle. Presumably, having the same number of double exposures as 
multiple exposures would result in the double exposures performing better. A similar observation 
can be made of the data presented in Table 5.  
The first two columns in Table 5 display the accuracies of a system trained solely on single 
exposure cases and tested against the secondary contributor for both multiple and double 
disorder cases. With average accuracies of 69.1% and 66.3%, the system performance is not 
stellar, however, it is high enough to raise a question: If the clinical effects in multiple exposure 
cases are dominated by the primary contributor, why is the accuracy in diagnosing the secondary 
contributor so high? Recall that during data cleaning all multiple exposure cases involving only 
products with the same generic substance code are removed from the dataset. This cleaning is 
only performed at the substance level. It is still likely that many multiple exposure cases consist 
of primary and secondary substances that share the same major and minor categories. Belonging 
to the same category makes it much more likely that the two substances exhibit similar clinical 
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effects. Examining the data, it was determined that 21.0% of the primary and secondary 
contributors in all multiple exposure cases belonged to the same major category and 11.6% 
belonged to the same minor category as well. Likewise, 21.9% of all primary contributors in 
double exposure cases belonged to the same major category and 11.1% belonged to the same 
minor category. Because these cases are more likely to be diagnosed correctly based on the 
primary contributor, the accuracies are falsely optimistic. 
The last two columns in Table 5 show the accuracies of a system trained on a combination 
of single exposures and the secondary contributors for either multiple exposures or double 
exposures. The addition of the secondary contributors improves the average system accuracy by 
9.1% for multiple exposure diagnosis and 9.3% for double exposure diagnosis. Such a significant 
jump in accuracy attests that, although dominated by the primary contributor’s clinical effects, 
secondary contributors do produce enough clinical effects that the system can be trained to at 
least recognize the most common multiple exposure combinations. Although some of the 
accuracy can be accounted for by prior probabilities, the results give hope that further research 
might enable reasonably accurate identification of secondary contributors. 
The final step necessary to fully explore the impact of combining multiple exposure cases 
with single exposure cases was to train a system with the combined data and use it to diagnose 
only single exposure cases (Table 6). The first column shows the accuracy of a system trained on 
single exposures alone when diagnosing single exposures. The second and third columns display 
the accuracies for systems trained on single exposures along with the primary contributors for 
either multiple or double exposures. The last two columns contain the accuracies of systems 
trained on single exposures along with the secondary contributors for either multiple or double 
exposures. Interestingly, those systems trained with the primary contributors increased the 
16 
 
average system accuracy from 74.6% to 74.9% when including multiple exposures and 75.1% 
when including double exposures. Although a minor increase, it is an increase nonetheless and 
lends further support to the conclusion that the clinical effects in multiple exposure cases are 
dominated by the primary contributor. Furthermore, the average accuracy for systems trained 
with secondary contributors decreased from 74.6% to 74.2% when including multiple exposures 
and 74.4% when including double exposures. A lower accuracy is to be expected since training 
on the secondary contributor would associate clinical effects caused by the primary contributor 
with the secondary contributor instead. The minimal change in accuracy can be partially 
explained by the multiple and double exposures that involve closely related substances from the 
same major and minor categories, as discussed above. Additionally, on average 33,855 single 
exposure cases were used to train the system on each cycle. The added 8,901 multiple exposure 
cases or 5,149 double exposure cases only account for approximately 20.8% and 13.2% of the 
training cases. 
4.  Conclusion 
The research presented continues the development of a prototype knowledge-based system 
by investigating the diagnosis of exposures to multiple toxins. The system intentionally uses 
simple computations, following the philosophy that “simpler, even trivial, processes are better 
than complicated ones if they are enough for the job of discovery” [33]. Such simplicity will 
become necessary for scalability as the FPIC database grows in size. Although lack of multiple 
exposure data inhibited the diagnosis of more than one substance at a time, system testing 
revealed that the clinical effects observed in multiple exposures tend to be dominated by a single 
substance, called the primary contributor. Training the system on a combined training set of both 
single exposures and primary contributors from multiple exposure cases yielded performances as 
17 
 
high as 86.9% accuracy when diagnosing primary contributors. More specifically, 86.9% of the 
cases were diagnosed in the top 13 out of 129 possible major and minor category combinations. 
Being able to diagnose the disorder causing the most detrimental clinical effects is certainly 
valuable. Once the primary contributor is treated, it becomes easier to identify the other 
contributors in a multiple exposure case. Furthermore, there is hope that the accuracy when 
simultaneously diagnosing multiple exposures will improve with the collection of more data. 
5.  Future work 
From the outset, a major objective of the research was to bypass the knowledge acquisition 
bottleneck by generating a knowledge-based system capable of producing meaningful and useful 
results without the need for an active, overseeing expert. This design principle inherently limited 
the designer from making any changes that required even a fundamental knowledge of 
toxicology. Now that the prototype is complete, several changes can be implemented for the 
betterment of the system. First, useless substance diagnoses, such as the “unknown drug” 
diagnosis, should be removed. Second, redundant substances, such as “aspirin: pediatric 
formulation,” “aspirin: unknown if adult or pediatric formulation,” and “aspirin: adult 
formulation,” should be consolidated into a single diagnosis. Third, the category divisions could 
be examined by a toxicologist to create groupings based primarily on clinical effects. For 
example, most opioids tend to exhibit similar clinical effects whereas the effects associated with 
spider bites vary greatly depending on the species of spider. Intelligently restructuring diagnostic 
groupings could greatly increase the accuracy and utility of the knowledge-based consultant. 
After refining the system, the next step is to field test the system at the FPIC by 
implementing the system directly on the FPIC’s dedicated SQL server. Based on these results, 
further improvements can be implemented. One possible concern is that, although the system 
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may perform well on toxic exposure cases as a whole, it may be more beneficial for the system 
to specialize on more difficult and deadly problems. In other words, it may be better to sacrifice 
accuracy on simple, routine exposures to increase the accuracy of the system on exposures that 
are dangerous and difficult to diagnose.  
Finally, the system could be converted into a program for knowledge discovery within 
toxicology. When training on cases in the database, the system identifies relationships between 
specific exposures and their clinical effects. While many of these relationships are already 
known, it is quite possible that the system is discovering new relationships that were previously 
undocumented. This is particularly true when characterizing multiple exposure cases, many of 
which have little documentation. Examining the relationships within a trained system could lead 
to new discoveries in the field of toxicology, as has been done in other medical fields [34,35]. 
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Table 1 
     Accuracy (varying cutoff for training) of system trained and tested on multiple exposures 
    Minimum exposure cases 
Diagnosed by Severity 10 15 20 25 
Substance Minor 33.5% 30.4% 29.0% 27.6% 
 
Moderate 30.0% 26.9% 25.3% 22.9% 
  Major 28.3% 23.3% 21.8% 18.5% 
Major and minor Minor 47.3% 43.6% 39.5% 38.2% 
categories Moderate 45.9% 42.1% 37.6% 36.5% 
  Major 37.6% 34.5% 30.9% 30.6% 
Major Minor 50.1% 46.8% 45.7% 43.4% 
category Moderate 47.2% 44.1% 43.0% 40.4% 
  Major 43.0% 39.6% 38.2% 36.5% 
  Average 40.3% 36.8% 34.5% 32.7% 
 
 
 
 
Table 2 
    Accuracy (varying ) of system trained and tested on multiple exposures 
Diagnosed by Severity  = 0.1  = 0.01  = 0.001 
Substance Minor 32.3% 33.5% 33.5% 
 
Moderate 29.0% 30.0% 29.8% 
  Major 26.4% 28.3% 28.0% 
Major and minor Minor 46.5% 47.3% 47.4% 
categories Moderate 44.6% 45.9% 46.1% 
  Major 35.0% 37.6% 38.3% 
Major Minor 49.4% 50.1% 50.2% 
category Moderate 46.1% 47.2% 47.2% 
  Major 39.5% 43.0% 43.4% 
  Average 38.8% 40.3% 40.4% 
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Table 3 
      Accuracy comparison of various systems for multiple exposure diagnosis     
  Exposure No prior Original Double Order Primary 
Diagnosed by severity probability accuracies exposures reversed correct 
Substance Minor 16.5% 33.5% 35.3% 42.4% 64.8% 
 
Moderate 17.5% 30.0% 30.9% 40.3% 63.0% 
  Major 23.9% 28.3% 28.5% 39.8% 63.7% 
Major and minor Minor 21.7% 47.3% 47.1% 54.0% 82.7% 
categories Moderate 23.0% 45.9% 45.1% 53.7% 82.9% 
  Major 23.5% 37.6% 42.3% 49.4% 81.2% 
Major Minor 24.2% 50.1% 50.8% 56.0% 81.3% 
category Moderate 23.7% 47.2% 47.1% 54.5% 81.5% 
  Major 22.7% 43.0% 42.0% 53.3% 80.9% 
  Average 21.9% 40.3% 41.0% 49.3% 75.8% 
 
 
 
 
Table 4 
     Accuracy diagnosing primary contributors using single exposures   
    Singles Singles Combined Combined 
  
diagnosing diagnosing diagnosing diagnosing 
Diagnosed by Severity multiples doubles multiples doubles 
Substance Minor 75.4% 75.2% 79.1% 77.5% 
 
Moderate 77.2% 77.3% 81.1% 79.3% 
  Major 78.7% 81.8% 83.5% 83.1% 
Major and minor Minor 77.8% 76.4% 80.4% 78.2% 
categories Moderate 81.3% 80.4% 83.3% 81.6% 
  Major 84.9% 84.9% 86.9% 86.2% 
Major Minor 74.4% 74.9% 77.7% 76.9% 
category Moderate 75.5% 76.2% 78.7% 78.5% 
  Major 75.8% 78.3% 79.9% 80.5% 
  Average 77.9% 78.4% 81.2% 80.2% 
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Table 5 
     Accuracy diagnosing secondary contributors using single exposures   
    Singles Singles Combined Combined 
  
diagnosing diagnosing diagnosing diagnosing 
Diagnosed by Severity multiples doubles multiples doubles 
Substance Minor 69.6% 68.6% 77.6% 75.7% 
 
Moderate 70.5% 69.5% 79.7% 77.6% 
  Major 69.5% 70.0% 81.6% 77.0% 
Major and minor Minor 67.8% 63.2% 78.3% 76.8% 
categories Moderate 73.0% 69.5% 82.4% 80.9% 
  Major 77.6% 76.2% 86.2% 83.9% 
Major Minor 62.1% 57.1% 71.4% 69.0% 
category Moderate 64.4% 59.7% 72.9% 70.2% 
  Major 67.4% 63.0% 74.3% 69.6% 
  Average 69.1% 66.3% 78.2% 75.6% 
 
 
 
 
Table 6 
      Comparison of system accuracies when diagnosing single exposure cases     
    Single Singles and Singles and Singles and Singles and 
  
exposures multiples doubles multiples doubles 
Diagnosed by Severity alone (primary) (primary) (secondary) (secondary) 
Substance Minor 68.3% 68.2% 68.4% 68.1% 68.2% 
 
Moderate 77.5% 78.2% 78.0% 77.4% 77.4% 
  Major 80.7% 81.4% 81.4% 80.6% 80.8% 
Major and minor Minor 69.0% 68.9% 69.0% 68.6% 68.8% 
categories Moderate 77.6% 77.7% 78.0% 77.2% 77.5% 
  Major 79.8% 80.6% 81.0% 80.6% 80.3% 
Major Minor 68.8% 68.4% 68.9% 67.6% 67.9% 
category Moderate 73.9% 74.3% 74.3% 73.4% 73.3% 
  Major 76.2% 75.9% 76.8% 74.7% 75.0% 
  Average 74.6% 74.9% 75.1% 74.2% 74.4% 
 
